Tracy Renee (Mcmillan) Luckhardt MD (She/Her)
Critical Care Medicine, Pleural Disease
Associate Professor, Medicine, University of Alabama at Birmingham School of Medicine
Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Luckhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified Pulmonary and Critical Care physician. I specialize in the diagnosis and treatment of Interstitial Lung Disease, including Idiopathic Pulmonary Fibrosis (IPF), ILD related to autoimmune disease and all other diffuse parenchymal disease. I am principal investigator on multiple industry-sponsored clinical trials in Interstitial Lung Disease.
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2004
LSU School of Medicine in ShreveportClass of 2000
Certifications & Licensure
AL State Medical License 2009 - 2025
NC State Medical License 2017 - 2021
SC State Medical License 2017 - 2021
MI State Medical License 2004 - 2010
IA State Medical License 2000 - 2004
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Pulmonary Fibrosis Foundation Patient Registry Start of enrollment: 2016 Mar 29
- Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2019 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsAssociation of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis.Meenakshi Sridhar, Sandeep Bodduluri, Lanier O'Hare, Scott Blumhoff, Maria Del Pilar Acosta Lara
Respiratory Research. 2024-02-08 - 2 citationsCanine acquired pneumonia caused by.Luis Lantigua Tatem, Todd Veale, Christopher Richardson, Tracy Luckhardt
Idcases. 2023-01-01 - 12 citationsCorrelates of survival after autoantibody reduction therapy for acute IPF exacerbations.Tejaswini Kulkarni, Vincent G. Valentine, Fei Fei, Thi K. Tran-Nguyen, Luisa D Quesada-Arias
Plos One. 2021-11-23
Press Mentions
The Summer Coronavirus Surge Has Started to Ebb, but Delta’s Danger RemainsAugust 19th, 2021
Precision Medicine: UAB Study Creates ‘Mini-Lung’ to Study Effect of Pulmonary Fibrosis DrugsJanuary 26th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
